Based on CDC | Is there credible scientific evidence that turmeric can prevent or treat endometrial cancer?

There is currently no high‑quality clinical evidence that turmeric (or curcumin, its main active component) prevents or treats endometrial (uterine) cancer in humans. Most supportive data come from laboratory and animal studies, and clinical evidence in cancer generally remains early‑stage and mixed. ^{[1] [2]}

What the science shows

• Preclinical signals, not clinical proof: Curcumin has shown anti‑inflammatory and anti‑proliferative effects in cell and animal models, and it can influence pathways related to cancer growth and survival. However, these effects have not translated into proven prevention or treatment benefits for cancers in people, and there are no completed clinical trials demonstrating benefit in endometrial cancer. ^{[1] [2]}
• Bioavailability issues: Curcumin is poorly absorbed when taken by mouth, is rapidly metabolized, and reaches low blood levels, which likely limits its effect in human tissues outside the gut. Early‑phase studies suggest it is generally safe, but very high doses are often needed to reach measurable systemic levels. ^[2]

Evidence in cancer care more broadly

• Some small or early trials in other cancers have explored curcumin as an adjunct to standard therapy, with mixed or limited signals and frequent challenges due to absorption. Overall, authoritative medical centers conclude that research is ongoing and not sufficient to recommend curcumin as a cancer prevention or treatment strategy at this time. ^{[1] [2]}

Safety, interactions, and practical considerations

• Drug interactions: Curcumin can interfere with cytochrome P450 enzymes and has the potential to interact with certain chemotherapy drugs, including cyclophosphamide and doxorubicin. This means it could alter how these drugs are processed in the body, so it’s important to discuss any supplement use with your oncology team. ^[2]
• Dosing uncertainties: Because of poor absorption and variable supplement quality, there is no established effective dose for cancer prevention or treatment, and high doses may be required for any systemic effect. ^[2]
• Guideline perspective: Public health guidance for uterine cancer treatment emphasizes that many complementary and alternative therapies have not been scientifically tested for safety or effectiveness, and users should review risks and benefits with their clinicians. This aligns with the current uncertainty around turmeric for endometrial cancer. ^{[3] [4]}

Bottom line

• Preclinical data suggest curcumin has biological activities relevant to cancer, but there is no credible clinical evidence that turmeric or curcumin prevents or treats endometrial cancer in humans. ^{[1] [2]}
• If you are considering turmeric or curcumin, especially during cancer treatment, it’s wise to consult your healthcare team due to possible drug interactions and the lack of proven benefit. ^{[2] [3] [4]}

Practical tips if you still wish to use turmeric

• Using turmeric as a spice in food is generally considered safe for most people and delivers relatively small amounts. Supplement forms (capsules, extracts) provide much higher doses and carry a greater risk of interactions, so medical review is recommended before starting. ^[2]
• If you are on chemotherapy or other systemic medications metabolized by the liver, avoid starting curcumin without oncologist approval due to potential cytochrome P450 interactions. ^[2]

---